Reporting owner · CIK 0001740963
Chopra Daveen
SEC Form 4 history across 1 companies, 14 transactions and 5 filings.
CVP, TMTT, IHFMCVP, TMTT, Surgical & IHFMEdwards Lifesciences Corp
Open-market transaction mix0% buys0 buys · 2 sales
Available history · May 03, 2026 – Sep 11, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT · IHFM | F · withholdingSEC filing ↗ | -$34.5kView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT · IHFM | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT · IHFM | S · saleSEC filing ↗ | -$2.78MView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT · IHFM | S · saleSEC filing ↗ | -$105kView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT · IHFM | M · exerciseSEC filing ↗ | $2.31MView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | M · exerciseDerivative securitySEC filing ↗ | $0View disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | F · withholdingSEC filing ↗ | -$602kView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | M · exerciseSEC filing ↗ | $0View disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | F · withholdingSEC filing ↗ | -$94.4kView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | F · withholdingSEC filing ↗ | -$56.0kView disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | A · grantSEC filing ↗ | $0View disclosure → | |
EWEdwards Lifesciences Corp | Chopra DaveenCVP · TMTT | F · withholdingSEC filing ↗ | -$23.6kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Edwards Lifesciences Corp on Aug 26, 2026 valued at $2,788,547.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 0 | 0 | $0.00 | $0.00 | $0.00 |
| Aug 2026 | 0 | 2 | $0.00 | $2,894,439.62 | -$2,894,439.62 |
| Sep 2026 | 0 | 0 | $0.00 | $0.00 | $0.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$1.4M
Median P/S size$1.4M
Direct14
Indirect0
Sep 11, 2026withholding
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
10 observations · May 3, 2026 – Sep 11, 2026. Window ends at the latest available report, not today.
Selected observation · Sep 11, 202643,926 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| May 3, 2026 | 31,919 | May 4, 2026 | View transaction |
| May 7, 2026 | 41,594 | May 9, 2026 | View transaction |
| May 7, 2026 | 40,920 | May 9, 2026 | View transaction |
| May 8, 2026 | 39,779 | May 9, 2026 | View transaction |
| May 11, 2026 | 53,362 | May 12, 2026 | View transaction |
| May 11, 2026 | 45,824 | May 12, 2026 | View transaction |
| Aug 26, 2026 | 76,124 | Aug 26, 2026 | View transaction |
| Aug 26, 2026 | 74,970 | Aug 26, 2026 | View transaction |
| Aug 26, 2026 | 44,324 | Aug 26, 2026 | View transaction |
| Sep 11, 2026 | 43,926 | Sep 11, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Chopra Daveen Insider Activity FAQ
SEC Form 4 context
Who is Chopra Daveen?
Chopra Daveen is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001740963.
Which companies has Chopra Daveen reported transactions for?
Edwards Lifesciences Corp
When was Chopra Daveen's latest insider buy?
No open-market insider purchase is available for this period.
When was Chopra Daveen's latest insider sale?
sale at Edwards Lifesciences Corp on Aug 26, 2026 valued at $2,788,547.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.